Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Beta2-adrenergic receptor genotype predicts survival: implications and future directions.

The Journal of cardiovascular nursing - 1 Jan 2000

Lanfear David E, Spertus John A, McLeod Howard L

Abstract excerpt

Our previously published data indicate that patients prescribed beta-blocker (BB) therapy after an acute coronary syndrome have differential survival associated with their ADRB2 genotypes. These sequence variants can risk-stratify patients receiving BB therapy and may predict BB efficacy post-acute coronary syndrome. This report summarizes our findings and describes their implications for clinical care as well as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adrenergic beta-Antagonists
Share to ADRB2 gene
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Myocardial Infarction

Share to Receptors, Adrenergic, beta-2

Source

Identifiers

PMID: 17293738
DOI: 10.1097/00005082-200611000-00011

Genes

ADRB2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Beta2-adrenergic receptor genotype predicts survival: implications and future directions.PMID 17293738Read ↗

Genetic polymorphisms in ADRB2 and ADRB1 are associated with differential survival in heart failure patients taking β-blockers.Semantic proximity Read ↗

Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome.Semantic proximity Read ↗

Association of beta-adrenergic receptor polymorphisms and mortality in carvedilol-treated chronic heart-failure patients.Semantic proximity Read ↗

β-Adrenergic Receptor Gene Polymorphisms and β-Blocker Treatment Outcomes in HypertensionSemantic proximity Read ↗

Effect of specific ADRB1/ADRB2/AGT genotype combinations on the association between survival and carvedilol treatment in chronic heart failure: a substudy of the ECHOS trial.Semantic proximity Read ↗

Adrenergic-Pathway Gene Variants Influence Beta-Blocker–Related Outcomes After Acute Coronary Syndrome in a Race-Specific MannerSemantic proximity Read ↗

The Beta-Blocker Pharmacogenetic Puzzle: More Pieces of Evidence for Pharmacodynamic Candidate Variants.Semantic proximity Read ↗

β-adrenergic receptor polymorphisms in susceptibility, response to treatment and prognosis in heart failure: implication of ethnicity.Semantic proximity Read ↗

Impact of the β-1 adrenergic receptor polymorphism on tolerability and efficacy of bisoprolol therapy in Korean heart failure patients: association between β adrenergic receptor polymorphism and bisoprolol therapy in heart failure (ABBA) study.Semantic proximity Read ↗

Beta2-adrenergic receptor genotype and pulmonary function in patients with heart failure.Semantic proximity Read ↗

Clinical and genetic modifiers of long-term survival in heart failure.Semantic proximity Read ↗

Beta-adrenoceptor polymorphisms and heart failure.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.